免疫療法による臨床試験の価値を どう高めるか?
Michael B Atkins1, David F Mcdermott2
1Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA mba41@Georgetown.edu.
Journal for immunotherapy of cancer
|August 27, 2025
まとめ
チェックポイント阻害剤を含む 癌の免疫療法は 40年以上に渡って 治療に革命を起こしてきました このレビューでは 将来のがんの免疫療法により 患者の治療成果を向上させるための 学んだことを取り上げています
科学分野:
- 腫瘍学
- 免疫学
- 薬理学について
背景:
- 癌の免疫療法は,インタールイキン-2に関する初期の研究から大幅に進歩しました.
- 免疫療法は今や 癌治療の礎石となり 世界的に患者の生存率を向上させています
- チェックポイント阻害剤は20種類以上の癌に承認されており,新しいアプローチが開発中です.
研究 の 目的:
- 癌の免疫療法薬開発の 40年の旅を振り返る
- 過去の成功と課題から学んだことを
- 将来の免疫療法の効率的な開発,承認,適用のための洞察を提供すること.
主な方法:
- 癌免疫療法に関する過去のデータと文献のレビュー.
- 規制当局の承認経路と臨床試験の結果の分析
- 免疫療法戦略の進化に関する専門家のコメント
主要な成果:
- チェックポイント阻害剤の免疫療法は多くのがんの治療の標準となっています.
- エンジニアリングされたサイトカイン,T細胞エンゲージャー,腫瘍性ウイルス,細胞療法を含む様々な免疫療法が進歩しています.
- 免疫療法によって寿命を延ばし,改善する点で大きな進展がありました.
結論:
- この分野は40年間の免疫療法研究と開発から貴重な教訓を得ています.
- この知識を活用することは 次世代の免疫療法の開発と臨床応用を加速させるのに不可欠です
- 免疫療法における 継続的な革新は 将来の癌治療に 大きな希望をもたらします
キーワード:
免疫療法関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


